Clinical AI,
grounded in science.
TORTUS Labs publishes peer-reviewed research on what it takes to deploy AI safely in clinical settings - drawn from over 2.5 million real NHS consultations.
A commitment to the
scientific process.
We publish across three research areas - LLM safety, ambient voice technology, and clinician wellbeing. Every claim, backed by a paper.
LLM safety in clinical settings.
Hallucination taxonomy, evaluation methodology, and the safety science behind ambient AI in clinical settings.
Ambient voice technology & clinical productivity.
Phase II–IV NHS trials, preprints, and real-world evaluations of ambient AI across paediatrics, emergency care, and pre-hospital settings.
Use of an ambient artificial intelligence tool to improve quality of clinical documentation.
Phase II evaluation at Great Ormond Street Hospital. The first NHS study of ambient AI for paediatric documentation - significant improvements in note quality and clinician cognitive load.
Multi-site evaluation of ambient voice technology across nine NHS sites.
The largest trial of ambient voice technology in the NHS to date - 17,000 patients, nine sites, £500k NHS England backing. Featured in the NHS Ten Year Plan. Lancet submission under review.
Ambient voice technology in the Emergency Department: throughput, time-on-record, and clinician experience.
Pilot at St George's University Hospital. 13.4% productivity gain, halved initial note time, and 47 minutes saved per ED shift.
Clinician wellbeing & cognitive load.
How EHR documentation drives burnout - and the measurable impact of ambient scribes on cognitive load, time-on-record, and direct patient care.
Setting the standard for clinical AI.
TORTUS was selected for Phase II of the MHRA AI Airlock - the UK regulator's sandbox for AI as a Medical Device. We co-developed the regulatory pathway for ambient voice technology alongside the MHRA.
The Phase 2 Programme Report, published 9 June 2026, sets out how AI medical devices should be evaluated, monitored, and brought to market in the UK.